Approaches to multiple myeloma management in gulf countries: A narrative review insights from the Kingdom of Saudi Arabia and gulf multiple myeloma experts

Fahad Z Al Sharif; Ahmad Alhuraiji; Arif Alam; Ayman Alhejazi; Hani Osman; Hesham El Sabah; Faraz Khan; Majed Alahmadi; Musa Alzahrani; Mustaqeem A Siddiqi; Omar Zeid Abdeljalil; Ahmed Hesham; Magdy Rabea; Waleed Hannout; Mahmoud Marashi

doi:10.4103/joah.joah_110_22

Users Online: 33531

REVIEW ARTICLE

Year : 2023 | Volume : 14 | Issue : 2 | Page : 71-77

Approaches to multiple myeloma management in gulf countries: A narrative review insights from the Kingdom of Saudi Arabia and gulf multiple myeloma experts

Fahad Z Al Sharif¹, Ahmad Alhuraiji², Arif Alam³, Ayman Alhejazi⁴, Hani Osman³, Hesham El Sabah⁵, Faraz Khan⁶, Majed Alahmadi⁷, Musa Alzahrani⁸, Mustaqeem A Siddiqi⁹, Omar Zeid Abdeljalil¹⁰, Ahmed Hesham¹¹, Magdy Rabea¹¹, Waleed Hannout¹¹, Mahmoud Marashi¹²
¹ Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
² Department of Hematology, Kuwait Cancer Control Center, Kuwait City, Kuwait
³ Department of Oncology, Tawam Hospital, Dubai, Saudi Arabia
⁴ Department of Oncology, King Abdulaziz Medical City, Dubai, Saudi Arabia
⁵ Hamad Medical Corporation, National Center for Cancer Care and Research, Dubai, Saudi Arabia
⁶ Department of Oncology, American Hospital, Dubai, Saudi Arabia
⁷ Department of Adult Hematology and HSCT, King AbdulAziz Medical City, King Saud bin Abdul Aziz University for Health Sciences, Riyadh, Saudi Arabia
⁸ Department of Medicine and Oncology Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia
⁹ Division of Oncology and Hematology, Sheikh Shakhbout Medical City, Abu Dhabi, Saudi Arabia
¹⁰ Department of Oncology, King Fahd Specialist Hospital in Dammam, Dammam, Saudi Arabia
¹¹ Department of Medical Affairs, Sanofi, GCC, Dubai, UAE
¹² Department of Hematology, Dubai Health Authority, Mediclinic City Hospital, Dubai, UAE

Correspondence Address:
Dr. Mahmoud Marashi
Department of Hematology, Dubai Health Authority, Mediclinic City Hospital, Dubai
UAE

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/joah.joah_110_22

Multiple myeloma (MM) is neoplasm of the plasma cells derived from the postgerminal B-cell lineage and it ranges from premalignant conditions like monoclonal gammopathy of unknown significance and smoldering MM (SMM) to malignant diseases such as overt MM. With advances in science and technology, the understanding of the disease has increased paving the way for advanced therapeutic options and better patient outcomes. Thus, this article is a narrative review summarizing the recent advances in the epidemiology, clinical presentation, risk stratification, and MM patient populations treatment and to provide insights by the authors who are experts in the field of MM management who are considered as Gulf Myeloma Working Group and who were the members of 'Approaches to MM Management' Advisory Board meeting held on October 29, 2021. The expert panel provided several recommendations and drawn consensus statements pertaining to MM management in the Gulf countries.

[FULL TEXT] [PDF]*

Table of Contents

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	1663

Printed	82

Emailed	0

PDF Downloaded	231

Comments	[Add]